"Watch and Wait" vs. Maintenance Treatment after Chemo with PARP Inhibitors

Presented by Jessica Moffett, Oncology Nurse Practitioner/Educator @ TESARO.

Date: April 25, 2019

Time: 6:30 PM to 7:30 PM

Join us via webinar, by computer or phone! Click this link PARP Inhibitors Education Webinar and watch along!

Meeting number: 621 287 474

Password: PaCtHWJf

OR, you may also join us by phone by dialing +1-510-338-9438

Access Code: 621 287 474

We suggest you join the meeting a few minutes early so you have enough time to download the WebEx software. 

Only your gynecologic oncologist (or medical oncologist) will know if a PARP Inhibitor is right for you!

Currently, there are only three available PARP Inhibitors:

  • Niraparib (aka Zejula) from Tesaro/GSK
  • Olaparib (aka Lynparza) from Astra Zeneca/Merck
  • Rucaparib (aka Rubraca) from Clovis Oncology